Preservation of human heart valves for replacement in children with heart valve disease: past, present and future.
Autor: | Peters MC; Department of Pediatric Cardiothoracic Surgery, Wilhelmina Children's Hospital, University Medical Center Utrecht, 3584 EA, Utrecht, The Netherlands. m.c.peters-11@umcutrecht.nl.; Department of Cardiovascular Cell Biology, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands. m.c.peters-11@umcutrecht.nl.; Department of Biomedical Engineering, Eindhoven University of Technology, 5600 MB, Eindhoven, The Netherlands. m.c.peters-11@umcutrecht.nl., Kruithof BPT; Department of Cardiovascular Cell Biology, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.; Department of Cardiology, Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands., Bouten CVC; Department of Biomedical Engineering, Eindhoven University of Technology, 5600 MB, Eindhoven, The Netherlands.; Institute for Complex Molecular Systems, Eindhoven University of Technology, 5600 MB, Eindhoven, The Netherlands., Voets IK; Institute for Complex Molecular Systems, Eindhoven University of Technology, 5600 MB, Eindhoven, The Netherlands.; Department of Chemical Engineering and Chemistry, Eindhoven University of Technology, 5600 MB, Eindhoven, The Netherlands., van den Bogaerdt A; Heart Valve Department, ETB-BISLIFE Multi Tissue Center, 2333 BD, Beverwijk, The Netherlands., Goumans MJ; Department of Cardiovascular Cell Biology, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands., van Wijk A; Department of Pediatric Cardiothoracic Surgery, Wilhelmina Children's Hospital, University Medical Center Utrecht, 3584 EA, Utrecht, The Netherlands. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cell and tissue banking [Cell Tissue Bank] 2024 Mar; Vol. 25 (1), pp. 67-85. Date of Electronic Publication: 2023 Feb 01. |
DOI: | 10.1007/s10561-023-10076-2 |
Abstrakt: | Valvular heart disease affects 30% of the new-borns with congenital heart disease. Valve replacement of semilunar valves by mechanical, bioprosthetic or donor allograft valves is the main treatment approach. However, none of the replacements provides a viable valve that can grow and/or adapt with the growth of the child leading to re-operation throughout life. In this study, we review the impact of donor valve preservation on moving towards a more viable valve alternative for valve replacements in children or young adults. (© 2023. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |